Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340727 · ClinicalTrials.gov registry record · Phase 3
Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
A Phase 3 study, sponsored by NICHD Neonatal Research Network.
- Terminated
- Registry status
- Phase 3
- Development phase
- 827
- Enrollment target
NCT03340727 is a Phase 3 study that was terminated before completion, run by NICHD Neonatal Research Network. The registered enrollment target is 827 participants.
The verdict
NCT03340727, a Phase 3 study, was terminated before completion, sponsored by NICHD Neonatal Research Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 827 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the effect of continuing treatment with caffeine citrate in the hospital and at home in moderately preterm infants with resolved apnea of prematurity on days of hospitalization after randomization.
Interventions
- DRUG Placebo
- DRUG Caffeine Citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 827 participants |
| Start Date | 2019-02-27 |
| Est. Completion | 2023-03-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340727
The ClinicalTrials.gov registry entry for NCT03340727 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 827 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03340727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03340727 about?
NCT03340727 is a clinical study titled "Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial". The objective of this study is to evaluate the effect of continuing treatment with caffeine citrate in the hospital and at home in moderately preterm infants with resolved apnea of prematurity on days of hospitalization after randomization.
What is the current status of trial NCT03340727?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 827 participants. The study started on 2019-02-27. Estimated completion is 2023-03-20.
What interventions are being tested in trial NCT03340727?
The interventions under investigation include: Placebo (DRUG), Caffeine Citrate (DRUG).
Who is sponsoring clinical trial NCT03340727?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.